1 hour ago
Pfizer (PFE) Stock: Analysts Lean Bullish Despite Lingering Valuation Questions
Pfizer (PFE) stock trades at 9.4x 2026 earnings with a 6.1% dividend yield. Wall Street says Moderate Buy, but valuation questions persist.
The post Pfizer (PFE) Stock: Analysts Lean Bullish Despite Lingering Valuation Questions appeared first on Blockonomi.
Source: Blockonomi →Related News
- 49 minutes ago
Regenxbio (RGNX) Stock Plummets 25% as FDA Halts Gene Therapy Trial
- 50 minutes ago
Archer Aviation (ACHR) Stock Soars 19% Following L.A. Live Vertiport Partnership...
- 51 minutes ago
Bernstein Boosts Airbnb (ABNB) Price Target to $217 Following Strong Q2 Performa...
- 52 minutes ago
Taiwan Charges Nvidia (NVDA) and Super Micro Staff in Illegal AI Chip Export Cas...
- 53 minutes ago
American Airlines (AAL) Stock Falls After Q4 Capacity Forecast Reduced Amid Trav...